Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Sep;3 Suppl 1(Suppl 1):S2-6.
doi: 10.1093/jpids/piu069.

Mother-to-Child Transmission of Cytomegalovirus and Prevention of Congenital Infection

Robert F Pass  1 , Brenna Anderson  2
Affiliations

Mother-to-Child Transmission of Cytomegalovirus and Prevention of Congenital Infection

Robert F Pass et al. J Pediatric Infect Dis Soc. 2014 Sep.

Abstract

Mother-to-child transmission (MTCT) of cytomegalovirus (CMV) occurs transplacentally (congenital infection), during birth and through breast milk, although the latter 2 modes of transmission are not associated with the central nervous system sequelae that occur with congenital infection. CMV persists indefinitely in its human host, and MTCT can occur if the mother was infected in the past or during the current pregnancy. The goal of efforts to prevent MTCT of CMV is to prevent congenital infection, an important cause of disability due to hearing loss, impaired vision, cognitive impairment, and neuromotor deficits. Vaccines for prevention of maternal and congenital CMV infection are being developed but will not likely be available for at least a decade. Rather than waiting for an effective vaccine to solve the problem, more effort must be devoted to defining the potential for public health measures to prevent congenital CMV infection by reducing rates of maternal infection during pregnancy.

Keywords: MTCT; congenital infection; cytomegalovirus; prevention.

PubMed Disclaimer

References

    1. Schleiss MR. Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis. Infect Disord Drug Targets. 2011;11:449–65. - PMC - PubMed
    1. Staras SA, Dollard SC, Radford K, et al. Cytomegalovirus infection in the United States: seroprevalence and demographic risk factors. Clin Infect Dis. 2006;43:1143–51. - PubMed
    1. Stagno S, Pass RF, Dworsky ME, Alford CA. Maternal cytomegalovirus infection and perinatal transmission. Clin Obstet Gynecol. 1982;25:563–76. - PubMed
    1. Griffiths PD, Baboonian C. A prospective study of primary cytomegalovirus infection during pregnancy: final report. Br J Obstet Gynaecol. 1984;91:307–15. - PubMed
    1. Leurez-Ville M, Salomon LJ, Stirnemann JJ, et al. Prediction of fetal infection in cases with cytomegalovirus immunoglobulin M in the first trimester of pregnancy: a retrospective cohort. Clin Infect Dis. 2013;56:1428–35. - PubMed